Skip to main content

Nanogen Licenses MDx Technology to Swedish Firm

NEW YORK (GenomeWeb News) – Nanogen said today that it has licensed to Scandinavian Gene Synthesis the rights to its MGB Probe technology and synthetic nucleic acid chemistries and dyes and quenchers.

Under the licensing deal, SGS has the right to use its own cGMP manufacturing capabilities to make and sell molecular diagnostic products incorporating Nanogen's technology. In return, Nanogen will receive an upfront license fee and a commitment for Nanogen to supply component products for use by SGS in designing and manufacturing custom DNA oligonucleotides for the molecular diagnostics market.

Further terms of the pact were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.